Baird Medical Investment signs US$ 4.35 million senior OID convertible note deal with institutional investor
Bitget2026/09/30 20:07- Baird Medical entered a Securities Purchase Agreement on Sept. 24, 2026 with an institutional investor for a senior 8% OID convertible promissory note.
- Issued a US$4,347,826 note with a 12-month term; no interest unless default triggers 15% annual interest, compounding monthly.
- Added a 2% OID, issuing 110,070 ordinary shares priced at US$0.79 as discount shares.
- Conversion price set at the lower of US$0.9842 or 92% of the lowest seven-day VWAP, subject to a floor price.
- Investor received first-priority security over U.S. subsidiary equity and substantially all U.S.-located assets; subsidiaries provided guarantees.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Edges Higher as Treasury Yields, Dollar Ease -- Market Talk
Morgan Stanley is tactically bullish on BHP (BHP.US): Two major copper mine catalysts may ignite the stock price in the next two months
Morgan Stanley maintains an "Overweight" rating on BHP Group, with an "attractive" industry outlook, and sets a target price of AUD 69.00 for its shares listed in Australia.
Bank of England hawkish official: Growth exceeds expectations and employment is resilient, which precisely proves that further rate hikes are necessary.
Megan Greene, a policymaker at the Bank of England, stated that the UK's economic growth surpassing expectations and the resilience of the job market indicate that the Bank of England's efforts to curb inflation are still insufficient.
Crypto prices
More
